GlobeNews Wire

Car Thermal Night Vision by Robofinity: Enhance 2025 Night Safety

Hong Kong, July 25, 2025 (GLOBE NEWSWIRE) -- As road safety takes center stage in 2025, Robofinity announces the release…

11 months ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a…

11 months ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

11 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis onAugust 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage…

11 months ago

Ambow Launches HybriU Global Learning Network, Connecting U.S. Universities with Students Worldwide

New Phygital Infrastructure Empowers U.S. Universities to Expand Globally Through AI-powered Hybrid Classrooms      CUPERTINO, Calif., July 25, 2025 (GLOBE NEWSWIRE)…

11 months ago

Aurora Mobile Leverages Quantum Computing to Accelerate Business Model Innovation

July 25, 2025 05:00 ET  | Source: Aurora Mobile Limited SHENZHEN, China, July 25, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile…

11 months ago

Nrburgring chooses vivenu: New partnership accelerates ticketing innovation

DÜSSELDORF, Germany and NÜRBURG, Germany, July 25, 2025 (GLOBE NEWSWIRE) -- Nürburgring, Germany’s largest sporting venue and one of the…

11 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the…

11 months ago

Abivax Announces Full Exercise of Underwriters Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) PARIS,…

11 months ago

Press Release: Sanofis Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase…

11 months ago